Repurposing existing medications for coronavirus disease 2019: protocol for a rapid and living systematic review

Repurposing existing medications for coronavirus disease 2019: protocol for a rapid and living systematic review

Abstract Background Coronavirus disease 2019 (COVID-19) has no confirmed specific treatments. However, there might be in vitro and early clinical data as well as evidence from severe acute respiratory syndrome and Middle Eastern respiratory syndrome that could inform clinicians and researchers. This...

Full description

Bibliographic Details
Main Authors:	Benjamin P. Geisler, Lara Zahabi, Adam Edward Lang, Naomi Eastwood, Elaine Tennant, Ljiljana Lukic, Elad Sharon, Hai-Hua Chuang, Chang-Berm Kang, Knakita Clayton-Johnson, Ahmed Aljaberi, Haining Yu, Chinh Bui, Tuan Le Mau, Wen-Cheng Li, Debbie Teodorescu, Ludwig Christian Hinske, Dennis L. Sun, Farrin A. Manian, Adam G. Dunn
Format:	Article
Language:	English
Published:	BMC 2021-05-01
Series:	Systematic Reviews
Subjects:	COVID-19 SARS-CoV2 Severe acute respiratory syndrome SARS Middle East respiratory syndrome Coronavirus MERS-CoV
Online Access:	https://doi.org/10.1186/s13643-021-01693-7

Similar Items

Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays
by: Francesca Curreli, et al.
Published: (2021-12-01)

In Silico Design of Peptide-Based SARS-CoV-2 Fusion Inhibitors That Target WT and Mutant Versions of SARS-CoV-2 HR1 Domains
by: Shana V. Stoddard, et al.
Published: (2021-07-01)

Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
by: Ahmad Tavakoli, et al.
Published: (2017-04-01)

Experimental Infection and Response to Rechallenge of Alpacas with Middle East Respiratory Syndrome Coronavirus
by: Gary Crameri, et al.
Published: (2016-06-01)

Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19
by: Faheem Hyder Pottoo, et al.
Published: (2021-02-01)

Editorial: Human coronavirus research: 20 years since the SARS-CoV outbreak
by: Burtram C. Fielding
Published: (2022-09-01)

Chemokine Regulation During Epidemic Coronavirus Infection
by: Shamik Majumdar, et al.
Published: (2021-02-01)

Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
by: Ridhima Kaul, et al.
Published: (2021-10-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

Comment on Alfassam et al. Development of a Colorimetric Tool for SARS-CoV-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold Nanoparticles. <i>Pharmaceutics</i> 2021, <i>13</i>, 502
by: Milad Zandi, et al.
Published: (2022-09-01)

Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach
by: Taimoor Khan, et al.
Published: (2022-04-01)

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
by: Sicong Yu, et al.
Published: (2021-06-01)

Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight
by: Chunting He, et al.
Published: (2020-07-01)

EMERGENCIA DE SARS-COV-2. ASPECTOS BÁSICOS SOBRE SU ORIGEN, EPIDEMIOLOGÍA, ESTRUCTURA Y PATOGENIA PARA CLÍNICOS
by: Jeannette Dabanch
Published: (2021-01-01)

Recent Chronology of COVID-19 Pandemic
by: Sazada Siddiqui, et al.
Published: (2022-05-01)

The interplay between emerging human coronavirus infections and autophagy
by: Zhenyu Zhao, et al.
Published: (2021-01-01)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
by: Yun-yu Zhang, et al.
Published: (2020-08-01)

Comparison of Clinical Features and Outcomes between SARS-CoV-2 and Non-SARS-CoV-2 Respiratory Viruses Associated Acute Respiratory Distress Syndrome: Retrospective Analysis
by: Manbong Heo, et al.
Published: (2022-04-01)

Comparative transcriptome analysis of SARS-CoV-2, SARS-CoV, MERS-CoV, and HCoV-229E identifying potential IFN/ISGs targets for inhibiting virus replication
by: Yuzhuang Liu, et al.
Published: (2023-12-01)

Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections
by: Ashutosh Khaswal, et al.
Published: (2022-07-01)

SARS, MERS and COVID-19-Associated Renal Pathology
by: Hristo Popov, et al.
Published: (2022-10-01)

Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects
by: Przemyslaw Wielgat, et al.
Published: (2020-08-01)

<i>Betacoronavirus</i> Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic
by: Alejandro Llanes, et al.
Published: (2020-06-01)

An Overview of the Pathogenesis, Transmission, Diagnosis, and Management of Endemic Human Coronaviruses: A Reflection on the Past and Present Episodes and Possible Future Outbreaks
by: Adeoye J. Kayode, et al.
Published: (2021-08-01)

Immune Profiling of COVID-19 in Correlation with SARS and MERS
by: Bariaa A. Khalil, et al.
Published: (2022-01-01)

Honokiol Inhibits SARS-CoV-2 Replication in Cell Culture at a Post-Entry Step
by: Clarisse Salgado-Benvindo, et al.
Published: (2023-06-01)

Contribution to pathogenesis of accessory proteins of deadly human coronaviruses
by: Jesus Hurtado-Tamayo, et al.
Published: (2023-05-01)

POTENTIAL RISK OF BRAIN DAMAGE AND POOR DEVELOPMENTAL OUTCOMES IN CHILDREN PRENATALLY EXPOSED TO SARS-COV-2: A SYSTEMATIC REVIEW
by: Marcio Leyser, et al.
Published: (2021-05-01)

The biological diversity of coronaviruses: where will the new threat come from?
by: Alexandr Khaitovich, et al.
Published: (2022-05-01)

Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives
by: Balasubramanian Ganesh, et al.
Published: (2021-04-01)

Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evidence
by: Jacques L. Tamuzi, et al.
Published: (2020-10-01)

Susceptibility to SARS-CoV-2 and MERS-CoV in Beagle Dogs
by: Kwang-Soo Lyoo, et al.
Published: (2023-02-01)

The relation between avian coronaviruses and SARS-CoV-2 coronavirus
by: Hanan Al-Khalaifah, et al.
Published: (2022-10-01)

Middle East Respiratory Syndrome Coronavirus, Saudi Arabia, 2017–2018
by: Ahmed Hakawi, et al.
Published: (2019-11-01)

Aromatic Herbs, Medicinal Plant-Derived Essential Oils, and Phytochemical Extracts as Potential Therapies for Coronaviruses: Future Perspectives
by: Mohamed Nadjib Boukhatem, et al.
Published: (2020-06-01)

Is The SARS-CoV2 Evolved in Human Being: A prospective Genetic Analysis
by: Salvatore Dimonte, et al.
Published: (2020-12-01)

Insight into 2019 novel coronavirus — An updated interim review and lessons from SARS-CoV and MERS-CoV
by: Mingxuan Xie, et al.
Published: (2020-05-01)

Antibodies against MERS Coronavirus in Dromedary Camels, United Arab Emirates, 2003 and 2013
by: Benjamin Meyer, et al.
Published: (2014-04-01)

Characteristics of Traveler with Middle East Respiratory Syndrome, China, 2015
by: Wen Da Guan, et al.
Published: (2015-12-01)